These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 32117219)
1. Targeting Extracellular Vesicles to the Arthritic Joint Using a Damaged Cartilage-Specific Antibody. Topping LM; Thomas BL; Rhys HI; Tremoleda JL; Foster M; Seed M; Voisin MB; Vinci C; Law HL; Perretti M; Norling LV; Azevedo HS; Nissim A Front Immunol; 2020; 11():10. PubMed ID: 32117219 [TBL] [Abstract][Full Text] [Related]
2. Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency. Hughes C; Sette A; Seed M; D'Acquisto F; Manzo A; Vincent TL; Lim NH; Nissim A Arthritis Res Ther; 2014 Jul; 16(4):R151. PubMed ID: 25029910 [TBL] [Abstract][Full Text] [Related]
3. Human single-chain variable fragment that specifically targets arthritic cartilage. Hughes C; Faurholm B; Dell'Accio F; Manzo A; Seed M; Eltawil N; Marrelli A; Gould D; Subang C; Al-Kashi A; De Bari C; Winyard P; Chernajovsky Y; Nissim A Arthritis Rheum; 2010 Apr; 62(4):1007-16. PubMed ID: 20131274 [TBL] [Abstract][Full Text] [Related]
5. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Lippross S; Moeller B; Haas H; Tohidnezhad M; Steubesand N; Wruck CJ; Kurz B; Seekamp A; Pufe T; Varoga D Arthritis Rheum; 2011 Nov; 63(11):3344-53. PubMed ID: 21769848 [TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
7. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance. Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798 [TBL] [Abstract][Full Text] [Related]
8. Peptide-directed liposomal delivery improves the therapeutic index of an immunomodulatory cytokine in controlling autoimmune arthritis. Meka RR; Venkatesha SH; Moudgil KD J Control Release; 2018 Sep; 286():279-288. PubMed ID: 30081142 [TBL] [Abstract][Full Text] [Related]
9. Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-α antibody in a murine model of rheumatoid arthritis. Katsumata K; Ishihara J; Fukunaga K; Ishihara A; Yuba E; Budina E; Hubbell JA Arthritis Res Ther; 2019 Dec; 21(1):298. PubMed ID: 31870429 [TBL] [Abstract][Full Text] [Related]
10. Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses. Hsiao HB; Hsieh CC; Wu JB; Lin H; Lin WC BMC Complement Altern Med; 2016 Feb; 16():80. PubMed ID: 26916550 [TBL] [Abstract][Full Text] [Related]
11. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis. Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614 [TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis. Kim H; Back JH; Han G; Lee SJ; Park YE; Gu MB; Yang Y; Lee JE; Kim SH Biomaterials; 2022 Jul; 286():121578. PubMed ID: 35594838 [TBL] [Abstract][Full Text] [Related]
14. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis. Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942 [TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways. Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675 [TBL] [Abstract][Full Text] [Related]
16. Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies. Lewthwaite J; Blake S; Hardingham T; Foulkes R; Stephens S; Chaplin L; Emtage S; Catterall C; Short S; Nesbitt A Ann Rheum Dis; 1995 May; 54(5):366-74. PubMed ID: 7794042 [TBL] [Abstract][Full Text] [Related]
17. Anti-TNF-α and anti-arthritic effect of patuletin: A rare flavonoid from Tagetes patula. Jabeen A; Mesaik MA; Simjee SU; Lubna ; Bano S; Faizi S Int Immunopharmacol; 2016 Jul; 36():232-240. PubMed ID: 27177082 [TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese medicine formula Bi-Qi capsule alleviates rheumatoid arthritis-induced inflammation, synovial hyperplasia, and cartilage destruction in rats. Wang K; Zhang D; Liu Y; Wang X; Zhao J; Sun T; Jin T; Li B; Pathak JL Arthritis Res Ther; 2018 Mar; 20(1):43. PubMed ID: 29540195 [TBL] [Abstract][Full Text] [Related]
19. Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis. Schwager K; Kaspar M; Bootz F; Marcolongo R; Paresce E; Neri D; Trachsel E Arthritis Res Ther; 2009; 11(5):R142. PubMed ID: 19781067 [TBL] [Abstract][Full Text] [Related]
20. A novel indomethacin/methotrexate/MMP-9 siRNA in situ hydrogel with dual effects of anti-inflammatory activity and reversal of cartilage disruption for the synergistic treatment of rheumatoid arthritis. Yin N; Tan X; Liu H; He F; Ding N; Gou J; Yin T; He H; Zhang Y; Tang X Nanoscale; 2020 Apr; 12(15):8546-8562. PubMed ID: 32243486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]